about
New and contemporary markers of prognosis in nonmuscle invasive urothelial cancerCell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomenaAssessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer.Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin.Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder.Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancerBiomarkers for prognosis and treatment selection in advanced bladder cancer patients.Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladderClinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.Developments in intravesical therapy for non-muscle-invasive bladder cancer.The cancer stem cell hypothesis: a guide to potential molecular targets.Noninvasive approaches for detecting and monitoring bladder cancer.Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo.Molecular expression profiling with respect to KEGG hsa05219 pathway.The determination of serum and urinary endocan concentrations in patients with bladder cancer.Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer.The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.
P2860
Q26798006-7CDF2E2A-FACE-4795-BEC5-E20C4E25A1CDQ26860953-D4FA526B-1AC1-4021-A18A-F00C66EDE331Q33976936-B54453D3-EE00-46E7-AE86-8C05A4B60439Q35245608-3268730F-11EC-41F6-87D0-3C283F04BF4EQ35440688-0D3AC870-7B13-4DB0-B71C-2B92E14A0D23Q35650689-D0862DB6-F439-4260-A117-294E95F6AF7FQ35671292-4C8AD09D-909A-409C-8F8A-CBD308FDC79AQ35681850-C62E3E09-9BBC-48B5-867C-D876821708FDQ36075206-2F1AFF24-7EA3-40A1-9A5D-94442979C0A5Q37298808-828131E1-C520-4C64-A9B0-CDBB57963D1AQ37812604-E3E86B2C-2254-4101-96EA-821899AFBF05Q38254181-E09266C4-8070-44FE-A47C-54BA7D8779C3Q38286089-D69FED3F-B862-4F97-9DF7-35D3DC91B1A9Q39107932-83E62AE7-7309-45A0-B8BA-26150329F170Q39368248-1C393D22-BFF2-4BA5-B787-1E2416D126F7Q40839414-89F22061-9496-4481-94FC-AF9C3D1BEE41Q43423183-6EE32CC0-F164-4317-A59F-D74240DFF623Q55465612-B0E60EA7-45C0-437F-B1B9-EB11340EBB2D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers in bladder cancer.
@en
Biomarkers in bladder cancer.
@nl
type
label
Biomarkers in bladder cancer.
@en
Biomarkers in bladder cancer.
@nl
prefLabel
Biomarkers in bladder cancer.
@en
Biomarkers in bladder cancer.
@nl
P2860
P50
P1433
P1476
Biomarkers in bladder cancer
@en
P2093
D Michael A Wallace
Nicholas D James
P2860
P304
P356
10.1111/J.1464-410X.2009.08880.X
P577
2009-09-29T00:00:00Z